CRISM Therapeutics Corporation (CRTX) — Cash Flow Quality Index

Latest as of June 2021: -4.43x

CRISM Therapeutics Corporation (CRTX) has a Cash Flow Quality Index of -4.43x as of June 2021. Operating cash flow of GBX-1.04 Million is below net income of GBX234.81K, suggesting accrual-heavy earnings not yet converted to cash. Explore CRTX debt coverage from operations to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-4.43x

Operating CF / Net Income

Operating Cash Flow

GBX-1.04 Million

GBX

Net Income

GBX234.81K

GBX

Data as of

Jun 2021

Most recent filing

Annual Cash Flow Quality Index for CRISM Therapeutics Corporation (None–None)

Year-by-year earnings quality comparison for CRISM Therapeutics Corporation.

Year	Quality Index	Operating CF (GBX)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.